記事一覧

• 大八木保政
  アルツハイマー病：脳の糖尿病の治療薬開発.
  老年期認知症研究会誌 2017; 21:46-49.

• 大八木保政
  アルツハイマー病.
  「今日の治療指針2017年度版」福井次矢・高木誠・小室一成 総編集 2017; 909-911.

• 伊賀瀬道也，岡田陽子，尾原麻耶，加藤丈陽，白岡朗，松本清香，千崎健佑，越智雅之，越智博文，大八木保政
  認知症予防の最前線.
  愛媛医学 2017; 36:77-81.

• 伊賀瀬道也
  認知症予防の最前線.
  総合健診 2017; 44:511-516.

• 越智博文
  自己免疫性脳炎に対するアフェレシス　多発性硬化症
  日本アフェレシス学会雑誌 2017; 36:3-8.

• Tabara Y, Igase M, Miki T, Ohyagi Y, Matsuda F, Kohara K; J-SHIPP study group.
  B-type natriuretic peptide is a determinant of the nocturnal increase in blood pressure independently of arterial hypertrophy and hypoxia.
  J Hypertens 2016; 34:2393-2401.

• Kawamura R, Tabara Y, Tsukada A, Igase M, Ohashi J, Yamada R, Takata Y, Kawamoto R, Saito I, Onuma H, Tanigawa T, Yamada K, Kato N, Ohyagi Y, Miki T, Kohara K, Osawa H.
  A genome-wide association study of plasma resistin levels identified rs1423096 and rs10401670 as possible functional variants in the Japanese population.
  Physiol Genomics 2016; 48:874-881.

• Fujii C, Kondo T, Ochi H, Okada Y, Hashi Y, Adachi T, Shin-Ya M, Matsumoto S, Takahashi R, Nakagawa M, Mizuno T.
  T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
  Sci Rep 2016; 6:35314

• Yamasaki R, Matsushita T, Fukazawa T, Yokoyama K, Fujihara K, Ogino M, Yokota T, Miyamoto K, Niino M, Nomura K, Tomioka R, Tanaka M, Kawachi I, Ohashi T, Kaida KI, Matsui M, Nakatsuji Y, Ochi H, Fukaura H, Kanda T, Nagaishi A, Togo K, Mizusawa H, Murai H, Kira J.
  Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
  Mult Scler 2016; 22:1337-1348.

• Tabara Y, Igase M, Miki T, Ohyagi Y, Matsuda F, Kohara K.
  Orthostatic hypertension as a predisposing factor for masked hypertension: the J-SHIPP study.
  Hypertens Res 2016; 39:664-669.

• Ochi H.
  B-cell-targeted therapy in multiple sclerosis.
  Clin Exp Neuroimmunol 2016; 7:260-271.

• Tabara Y, Kohara K, Ochi M, Okada Y, Ohara M, Nagai T, Igase M.
  Association of office-based frailty score with hypertensive end organ damage in the J-SHIPP cross-sectional study.
  Int J Cardiol 2016; 216:25-31.